EBD GmbH is part of the Knowledge & Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe Spring EBD Group BIO BIO-Europe Spring
Share/Follow Us
Share this:
Follow this event:

BIO-Europe Spring® 2016 Press Releases

July 30, 2014Spotlight on Stockholm/Uppsala Region Business Facts The Stockholm-Uppsala region, defined as the three counties of Uppsala, Stockholm and Sörmland, is one of the largest life science clusters in Europe. Stockholm-Uppsala region is Scandinavia's leading life science cluster and one of the world's most productive, and is one of the most competitive business environments in Europe. On average, an astounding 15–20 new...  more ►

partnering360® Blog

November 20, 2015 World domination, and five other great partnering360® uses you might be missing During BIO-Europe® 2015, held in Munich in early November, EBD Group asked attendees to share their experiences using partnering360®. Responses ranged from strategy planning before and after the event, and scouting for opportunities, to reading the latest news on this blog. A favorite response was... more ►

November 18, 2015 Biolatam® 2015 wraps up with huge success – event recap and photos Santiago de Chile was the center of life science innovation this week during Biolatam® 2015. The event, held November 16–17, buzzed with activity from international life science dealmakers from pharma, biotech, investors and service companies looking to forge collaborations that will fuel drug... more ►

November 13, 2015 How dedicated are you? One delegate’s near-heroic adventure to get to BIO-Europe® 2015 Your meeting schedule is full, your hotel booked; all that’s left is to get to the venue. Simple, right? Not necessarily.   For many, getting to BIO-Europe® 2015 took new forms of dedication, strategy and stamina as dense fog at Heathrow sidelined more than a few travelers this year. But for... more ►

November 10, 2015 Pfizer Chile’s Gloria Maldonado explains the value of life science partnering opportunities in Latin America Biolatam® 2015 global life science partnering event takes place in Chile in just one week, and will welcome a wide audience made up of pharma dealmakers, innovative and interesting biotech companies and a variety of new partners. There are vast opportunities for companies in the space, as evidenced... more ►

November 4, 2015 Nanomedicine Award winners announced at BIO-Europe® 2015 in Munich this week The second edition of the Nanomedicine Award ceremony took place On November 3, 2015, at BIO-Europe® 2015 in Munich, Germany. The European Technology Platform for Nanomedicine (ETPN) and the EU-funded consortium, ENATRANS, presented the Nanomedicine Award to honor the best international... more ►

partnering360:Insight Latest headlines from partnering360:Insight

November 4, 2015 Exciting science converges with strong money markets for record year in dealmaking The Tuesday plenary session at BIO-Europe® is possibly the favorite moment for the Monday Morning Quarterbacks in the biopharma industry, a chance to not only hear about the year's biggest deals, but to kick around questions with the people who put those deals together. more ►

November 4, 2015 Rushing for I/O combinations, pharma opens discovery with no-strings partnerships There are days when it seems the pharma universe turns around combination immuno-oncology therapy, that it is the only drug discovery and development activity. The first results that seem to present a real cure for some cancers have stirred an enthusiasm not typically linked to the pharma industry. more ►

November 4, 2015 Regenerative Medicine 3.0 : Is it real this time? Cell therapy is back and bigger than ever. In the mid-1990s, companies raised hundreds of millions of dollars to fund the promise of cell therapy, noted Mike Ward, Global Director of Content for Informa Pharma Insights. "And it went nowhere. Literally billions of dollars were spent back then, and just as quickly it all disappeared." more ►

November 4, 2015 Microbiome to disrupt traditional drug discovery and development There is something intuitive about microbiome—the flora in our bodies—that everyone understands. When this homeostasis is disrupted or thrown out of balance the resulting dysbiosis can contribute to disease. more ►

November 4, 2015 Small company dealmaking shooting for a record year in 2015 Large company M&A continues to dominate headlines with estimates for the year surpassing USD 200 billion in total value. That is above records set in 2014, a year that saw a flurry of pharma franchise swapping and further consolidation in the specialty pharma space. more ►

Arrow Up

Follow this event:
Sign up now
For news and updates

Privacy Policy and Cookies Terms of Use

Home | Contact Us | Site Map
See more upcoming conferences ►

EBD Group's Family of Events

© 2009–2015 EBD GmbH
Privacy Policy and Cookies
Terms of Use